DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,516,762 | +0.4% | 14,175 | -2.9% | 1.64% | +5.1% |
| Q2 2023 | $3,503,040 | -6.4% | 14,596 | -1.7% | 1.56% | -11.3% |
| Q1 2023 | $3,742,939 | -5.4% | 14,851 | -0.3% | 1.76% | -9.1% |
| Q4 2022 | $3,955,320 | -1.7% | 14,903 | -4.3% | 1.93% | -4.5% |
| Q3 2022 | $4,022,000 | +2.2% | 15,573 | +0.3% | 2.02% | +11.8% |
| Q2 2022 | $3,937,000 | -14.9% | 15,528 | -1.6% | 1.81% | -0.5% |
| Q1 2022 | $4,628,000 | -14.3% | 15,778 | -3.9% | 1.82% | -8.8% |
| Q4 2021 | $5,401,000 | +6.8% | 16,416 | -1.1% | 2.00% | -3.2% |
| Q3 2021 | $5,055,000 | +5.7% | 16,603 | -6.8% | 2.06% | +3.0% |
| Q2 2021 | $4,781,000 | +13.8% | 17,818 | -4.6% | 2.00% | +11.4% |
| Q1 2021 | $4,202,000 | -4.1% | 18,668 | -5.3% | 1.80% | -15.2% |
| Q4 2020 | $4,380,000 | +1.0% | 19,718 | -2.1% | 2.12% | -12.9% |
| Q3 2020 | $4,338,000 | +17.1% | 20,147 | -3.8% | 2.43% | +10.9% |
| Q2 2020 | $3,705,000 | +28.0% | 20,952 | +0.2% | 2.19% | +5.9% |
| Q1 2020 | $2,895,000 | -10.7% | 20,917 | -1.0% | 2.07% | +10.8% |
| Q4 2019 | $3,242,000 | +4.2% | 21,124 | -2.0% | 1.87% | -4.5% |
| Q3 2019 | $3,112,000 | -6.0% | 21,547 | -7.0% | 1.95% | -0.1% |
| Q2 2019 | $3,310,000 | +4.4% | 23,160 | -3.6% | 1.96% | +0.1% |
| Q1 2019 | $3,170,000 | +25.8% | 24,015 | -1.7% | 1.96% | +10.6% |
| Q4 2018 | $2,520,000 | -3.9% | 24,434 | +1.2% | 1.77% | +7.6% |
| Q3 2018 | $2,622,000 | +8.8% | 24,135 | -1.2% | 1.64% | +2.8% |
| Q2 2018 | $2,411,000 | -5.1% | 24,429 | -5.8% | 1.60% | -4.3% |
| Q1 2018 | $2,540,000 | +5.9% | 25,943 | +0.4% | 1.67% | +6.6% |
| Q4 2017 | $2,399,000 | +7.0% | 25,843 | -1.1% | 1.57% | +4.3% |
| Q3 2017 | $2,242,000 | +4.7% | 26,136 | +2.9% | 1.50% | +3.4% |
| Q2 2017 | $2,142,000 | -1.0% | 25,389 | +0.4% | 1.45% | -4.2% |
| Q1 2017 | $2,163,000 | +13.1% | 25,285 | +2.9% | 1.52% | +5.1% |
| Q4 2016 | $1,912,000 | -0.7% | 24,570 | -0.0% | 1.44% | -9.4% |
| Q3 2016 | $1,926,000 | -22.0% | 24,578 | +0.6% | 1.59% | -25.6% |
| Q2 2016 | $2,469,000 | +7.0% | 24,443 | +0.5% | 2.14% | +0.8% |
| Q1 2016 | $2,308,000 | +0.9% | 24,332 | -1.2% | 2.12% | +2.6% |
| Q4 2015 | $2,288,000 | +8.4% | 24,633 | -0.5% | 2.07% | +0.5% |
| Q3 2015 | $2,110,000 | -1.2% | 24,769 | -0.7% | 2.06% | +5.6% |
| Q2 2015 | $2,136,000 | -7.9% | 24,954 | -8.6% | 1.95% | -7.4% |
| Q1 2015 | $2,319,000 | -4.3% | 27,314 | -3.4% | 2.10% | -9.8% |
| Q4 2014 | $2,423,000 | +15.2% | 28,274 | +2.1% | 2.33% | +8.6% |
| Q3 2014 | $2,103,000 | -3.6% | 27,679 | -0.2% | 2.15% | -5.5% |
| Q2 2014 | $2,182,000 | +0.5% | 27,725 | -4.3% | 2.27% | -2.9% |
| Q1 2014 | $2,172,000 | -3.6% | 28,960 | -0.8% | 2.34% | -6.2% |
| Q4 2013 | $2,253,000 | +10.3% | 29,190 | -0.9% | 2.50% | +1.0% |
| Q3 2013 | $2,042,000 | +11.3% | 29,460 | +1.6% | 2.47% | +0.2% |
| Q2 2013 | $1,835,000 | – | 29,000 | – | 2.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |